CFIA
Cantor Fitzgerald Investment Advisors’s Bristol-Myers Squibb BMY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.6M | Buy |
271,448
+548
| +0.2% | +$25.4K | 0.89% | 44 |
|
|
2025
Q1 | $16.5M | Sell |
270,900
-24,820
| -8% | -$1.51M | 1.2% | 25 |
|
|
2024
Q4 | $16.7M | Buy |
295,720
+183
| +0.1% | +$10.4K | 1.16% | 29 |
|
|
2024
Q3 | $15.3M | Buy |
295,537
+529
| +0.2% | +$27.4K | 1.04% | 44 |
|
|
2024
Q2 | $12.3M | Buy |
295,008
+63,737
| +28% | +$2.65M | 0.94% | 48 |
|
|
2024
Q1 | $12.5M | Sell |
231,271
-2,903
| -1% | -$157K | 0.93% | 46 |
|
|
2023
Q4 | $12M | Buy |
+234,174
| New | +$12M | 0.93% | 43 |
|
|
2022
Q1 | $22.4M | Buy |
306,176
+146,248
| +91% | +$10.7M | 1% | 41 |
|
|
2021
Q4 | $9.97M | Buy |
159,928
+2,509
| +2% | +$156K | 0.6% | 48 |
|
|
2021
Q3 | $9.31M | Buy |
157,419
+430
| +0.3% | +$25.4K | 0.69% | 47 |
|
|
2021
Q2 | $10.5M | Buy |
+156,989
| New | +$10.5M | 0.77% | 41 |
|